Aldevron News

Aldevron Names Cynthia Biffert Vice President of its GMP Nucleic Acids Business Unit

Aldevron, the leading plasmid DNA manufacturing company, has expanded its leadership team by appointing Cynthia Biffert as Vice President of its GMP Nucleic Acids Business Unit (NABU) 


Biffert will work closely with functional leads to ensure the growth strategy, client communication, and project execution have strong operational alignment to support the strategic initiatives of the business unit. She will provide additional leadership and further structure while focusing on current and potential clients to help grow sales and to foster long-term relationships in the U.S. and global markets. 

Cynthia joined Aldevron in 2002 and serves as a mirror for the evolution our company has undergone,” said Michelle Berg, President of Aldevron’s GMP NABU. “Cynthia brings nearly two decades of experience with the company, our clients and the work they are doing to impact the lives of others. Her unique expertise makes her custom-built for this new role.”  

Biffert started her career with Aldevron in upstream manufacturing, helped establish the company’s QC department as QC Manager, assisted in the creation of Aldevron’s proprietary GMP-Source® quality system and the deployment of the GMP service lines as a Director of Biomanufacturing. She most recently served as Senior Director of Biomanufacturing where she helped launch neoGMP®, a service level allowing for personalized medicine. 

I am thankful that I could be a part of Aldevron’s growth over the past 18 years and contribute to the evolution of our industry,” said Biffert. “In this new role, I am able to take my manufacturing and quality experience to further support our current client’s research and share it with potential clients as well. As a leader in the GMP plasmid DNA bioscience space, I look forward to building upon our reputation of great service and the highest quality products.”   

Aldevron’s mission is to make meaningful changes worldwide through the quality biologics manufactured and value provided to clients. Our best ability to accomplish this important objective is through recruitment, development and retention of top talent, said Michael Chambers, Founding CEO and Executive Chairman of Aldevron’s Board of Directors. We are proud to promote from within our organization. Cynthia’s promotion comes at the ideal time as we build our additional 189,000 square-foot GMP facility, expected to be operational in early 2021.” 

Biffert graduated with B.S. degrees in Biology and Chemistry from North Dakota State University, Fargo, N.D. Prior to joining Aldevron Cynthia was employed in the microbiology laboratory at MeritCare, now Sanford, hospital, Fargo

Topics: Clinical Grade Manufacturing/cGMP